atomoxetine hydrochloride has been researched along with citalopram in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.00) | 18.2507 |
| 2000's | 6 (24.00) | 29.6817 |
| 2010's | 15 (60.00) | 24.3611 |
| 2020's | 3 (12.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Gackenheimer, SL; Gehlert, DR; Schober, DA | 1 |
| Blackwell, AD; Chamberlain, SR; Clark, L; Müller, U; Robbins, TW; Sahakian, BJ | 1 |
| Chamberlain, SR; Cleary, S; Müller, U; Robbins, TW; Sahakian, BJ | 1 |
| de Leon, J | 1 |
| Bomsien, S; Skopp, G | 1 |
| Harris, DK; Párraga, HC; Párraga, MI | 1 |
| Bari, A; Eagle, DM; Mar, AC; Robbins, TW; Robinson, ES | 1 |
| Jensen, NH; Karlsson, JJ; Miller, S; Montezinho, LP; Mørk, A; Plath, N; Witten, L | 1 |
| Bellgrove, MA; Cummins, TD; Dean, AJ; Garner, K; Hester, R; Kim, BN; Mattingley, JB; Nandam, LS; Nathan, PJ; Wagner, J | 1 |
| Baarendse, PJ; Vanderschuren, LJ | 1 |
| Bellgrove, MA; Hester, R; Mattingley, JB; Nandam, LS; Nathan, PJ; O'Connell, RG; Strudwick, M; Wagner, J | 1 |
| Barnes, JJ; Bellgrove, MA; Dean, AJ; Nandam, LS; O'Connell, RG | 1 |
| Anagnostaras, SG; Carmack, SA; Howell, KK; Rasaei, K; Reas, ET | 1 |
| Bellgrove, MA; Hester, R; Nandam, LS | 1 |
| Browne, CJ; Fletcher, PJ; Zeeb, FD | 1 |
| Altena, E; Barker, RA; Coyle-Gilchrist, I; Ham, T; Housden, CR; Jones, PS; Maxwell, H; Nombela, C; Rae, CL; Regenthal, R; Rittman, T; Robbins, TW; Rodríguez, PV; Rowe, JB; Sahakian, BJ; Ye, Z | 1 |
| Barygin, OI; Belinskaya, DA; Nagaeva, EI; Shestakova, NN; Tikhonov, DB; Vanchakova, NP | 1 |
| Horder, J; Matthews, PRL; Pearce, M | 1 |
| Buchanan, GF; Dayton, KG; Kruse, SW; Purnell, BS; Rosner, JI | 1 |
| Barnes, JJM; Bellgrove, MA; Brosnan, MB; Dean, A; Loughnane, GM; Nandam, SL; O'Connell, RG | 1 |
| Aigner, A; Ersche, KD; Regenthal, R; Rowe, JB; Sacher, J; Skandali, N; Teichert, J | 1 |
| Brittain, JR; Campbell-Meiklejohn, D; Cutler, J; Holmes, CL; Levstek, M; Livermore, JJ; Moga, G | 1 |
| Andrillon, T; Bellgrove, MA; Dockree, PM; O'Connell, RG; Pinggal, E | 1 |
2 review(s) available for atomoxetine hydrochloride and citalopram
| Article | Year |
|---|---|
The crucial role of the therapeutic window in understanding the clinical relevance of the poor versus the ultrarapid metabolizer phenotypes in subjects taking drugs metabolized by CYP2D6 or CYP2C19.
Topics: Alleles; Anti-Ulcer Agents; Antidepressive Agents, Tricyclic; Aryl Hydrocarbon Hydroxylases; Atomoxetine Hydrochloride; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Genetic Variation; Humans; Mixed Function Oxygenases; Omeprazole; Pharmacogenetics; Phenotype; Propylamines; Racial Groups | 2007 |
Selective noradrenaline reuptake inhibitors for schizophrenia.
Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Citalopram; Cognition; Humans; Morpholines; Quality of Life; Randomized Controlled Trials as Topic; Reboxetine; Schizophrenia; Serotonin and Noradrenaline Reuptake Inhibitors; Viloxazine | 2018 |
9 trial(s) available for atomoxetine hydrochloride and citalopram
| Article | Year |
|---|---|
Neurochemical modulation of response inhibition and probabilistic learning in humans.
Topics: Adult; Atomoxetine Hydrochloride; Citalopram; Double-Blind Method; Feedback, Psychological; Humans; Inhibition, Psychological; Learning; Male; Neural Inhibition; Norepinephrine; Prefrontal Cortex; Propylamines; Psychomotor Performance; Selective Serotonin Reuptake Inhibitors; Serotonin | 2006 |
Atomoxetine increases salivary cortisol in healthy volunteers.
Topics: Administration, Oral; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Blood Pressure; Capsules; Citalopram; Double-Blind Method; Heart Rate; Humans; Hydrocortisone; Male; Pituitary-Adrenal Function Tests; Propylamines; Reference Values; Saliva; Salivary Glands; Selective Serotonin Reuptake Inhibitors; Time Factors | 2007 |
Methylphenidate but not atomoxetine or citalopram modulates inhibitory control and response time variability.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Citalopram; Cross-Over Studies; Dopamine Uptake Inhibitors; Double-Blind Method; Humans; Inhibition, Psychological; Male; Methylphenidate; Neuropsychological Tests; Propylamines; Reaction Time; Selective Serotonin Reuptake Inhibitors | 2011 |
Neurochemical enhancement of conscious error awareness.
Topics: Adolescent; Adult; Analysis of Variance; Atomoxetine Hydrochloride; Awareness; Brain Mapping; Central Nervous System Stimulants; Citalopram; Consciousness; Cross-Over Studies; Double-Blind Method; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Inhibition, Psychological; Magnetic Resonance Imaging; Male; Methylphenidate; Neuropsychological Tests; Oxygen; Parietal Lobe; Photic Stimulation; Propylamines; Reaction Time; Time Factors; Young Adult | 2012 |
Monoaminergic modulation of behavioural and electrophysiological indices of error processing.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Citalopram; Cross-Over Studies; Dopamine Uptake Inhibitors; Double-Blind Method; Evoked Potentials; Executive Function; Female; Humans; Male; Methylphenidate; Neuropsychological Tests; Propylamines; Psychomotor Performance; Reaction Time; Selective Serotonin Reuptake Inhibitors; Young Adult | 2014 |
Dissociable and common effects of methylphenidate, atomoxetine and citalopram on response inhibition neural networks.
Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Awareness; Brain; Citalopram; Double-Blind Method; Executive Function; Humans; Image Processing, Computer-Assisted; Inhibition, Psychological; Magnetic Resonance Imaging; Male; Methylphenidate; Neural Pathways; Neuropsychological Tests; Neurotransmitter Agents; Oxygen; Propylamines; Visual Analog Scale; Young Adult | 2014 |
Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures.
Topics: Adrenergic Uptake Inhibitors; Aged; Atomoxetine Hydrochloride; Brain; Citalopram; Cross-Over Studies; Double-Blind Method; Female; Humans; Inhibition, Psychological; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Parkinson Disease; Prognosis; Psychomotor Performance; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors | 2016 |
Catecholamine Modulation of Evidence Accumulation during Perceptual Decision Formation: A Randomized Trial.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Brain; Catecholamines; Citalopram; Cross-Over Studies; Decision Making; Dopamine Uptake Inhibitors; Double-Blind Method; Electroencephalography; Evoked Potentials, Visual; Humans; Male; Methylphenidate; Middle Aged; Selective Serotonin Reuptake Inhibitors; Visual Perception; Young Adult | 2019 |
Pharmacological Manipulations of Physiological Arousal and Sleep-Like Slow Waves Modulate Sustained Attention.
Topics: Atomoxetine Hydrochloride; Attention; Citalopram; Dopamine; Electroencephalography; Humans; Male; Methylphenidate; Norepinephrine; Serotonin; Sleep; Wakefulness | 2022 |
14 other study(ies) available for atomoxetine hydrochloride and citalopram
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of (R)-[3H]tomoxetine and (R/S)-[3H]nisoxetine binding in rat brain.
Topics: Animals; Atomoxetine Hydrochloride; Autoradiography; Binding Sites; Brain; Citalopram; Desipramine; Fluoxetine; Male; Norepinephrine; Propylamines; Rats; Rats, Sprague-Dawley; Stereoisomerism; Tritium | 1995 |
An in vitro approach to potential methadone metabolic-inhibition interactions.
Topics: Algorithms; Amitriptyline; Analgesics, Opioid; Atomoxetine Hydrochloride; Chromatography, Liquid; Citalopram; Clozapine; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Isoenzymes; Kinetics; Methadone; Methylation; N-Methyl-3,4-methylenedioxyamphetamine; Oxidoreductases, N-Demethylating; Propylamines; Psychotropic Drugs; Pyridines; Pyrrolidines; Tandem Mass Spectrometry; Zolpidem | 2007 |
Tic exacerbation and precipitation during atomoxetine treatment in two children with attention-deficit hyperactivity disorder.
Topics: Adrenergic Uptake Inhibitors; Antipsychotic Agents; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Citalopram; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Propylamines; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Tics | 2007 |
Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats.
Topics: Analysis of Variance; Animals; Atomoxetine Hydrochloride; Behavior, Animal; Citalopram; Conditioning, Operant; Dopamine; Dose-Response Relationship, Drug; Guanfacine; Inhibition, Psychological; Male; Neurotransmitter Uptake Inhibitors; Norepinephrine; Piperazines; Propylamines; Rats; Reaction Time; Selective Serotonin Reuptake Inhibitors; Serotonin; Task Performance and Analysis; Time Factors | 2009 |
The effects of acute treatment with escitalopram on the different stages of contextual fear conditioning are reversed by atomoxetine.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Citalopram; Conditioning, Psychological; Dopamine; Drug Interactions; Fear; Hippocampus; Male; Microdialysis; Norepinephrine; Propylamines; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin | 2010 |
Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Animals, Outbred Strains; Atomoxetine Hydrochloride; Choice Behavior; Citalopram; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Impulsive Behavior; Male; Piperazines; Propylamines; Rats; Reaction Time; Selective Serotonin Reuptake Inhibitors; Serial Learning; Time Factors | 2012 |
Animal model of methylphenidate's long-term memory-enhancing effects.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Atomoxetine Hydrochloride; Bupropion; Central Nervous System Stimulants; Citalopram; Cocaine; Conditioning, Classical; Dose-Response Relationship, Drug; Fear; Female; Locomotion; Male; Maze Learning; Memory, Long-Term; Methylphenidate; Mice; Mice, Inbred C57BL; Nootropic Agents; Propylamines; Reinforcement, Psychology; Selective Serotonin Reuptake Inhibitors; Space Perception | 2014 |
Responding for a conditioned reinforcer or unconditioned sensory reinforcer in mice: interactions with environmental enrichment, social isolation, and monoamine reuptake inhibitors.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Citalopram; Conditioning, Classical; Environment; Male; Mice; Mice, Inbred C57BL; Motivation; Reinforcement, Psychology; Saccharin; Selective Serotonin Reuptake Inhibitors; Social Isolation | 2016 |
Inhibition of the NMDA and AMPA receptor channels by antidepressants and antipsychotics.
Topics: Amitriptyline; Animals; Antidepressive Agents; Antipsychotic Agents; Atomoxetine Hydrochloride; Brain; Chlorpromazine; Citalopram; Desipramine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fluoxetine; Magnesium; Male; Membrane Potentials; N-Methylaspartate; Neurons; Neurotransmitter Agents; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate | 2017 |
Effect of monoamine reuptake inhibition and α
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Citalopram; Duloxetine Hydrochloride; Electroshock; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Norepinephrine; Prazosin; Reboxetine; Seizures; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin and Noradrenaline Reuptake Inhibitors; Sudden Unexpected Death in Epilepsy | 2019 |
Determination of atomoxetine or escitalopram in human plasma by HPLC: Applications in neuroscience research studies
.
Topics: Atomoxetine Hydrochloride; Chromatography, High Pressure Liquid; Citalopram; Drug Monitoring; Humans; Reproducibility of Results; Tandem Mass Spectrometry | 2020 |
Selective effects of serotonin on choices to gather more information.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Choice Behavior; Citalopram; Decision Making; Double-Blind Method; Female; Humans; Impulsive Behavior; Information Seeking Behavior; Male; Risk-Taking; Selective Serotonin Reuptake Inhibitors; Serotonin; Young Adult | 2021 |